Charles Albright

Chief Tech/Sci/R&D Officer at

Affinia Therapeutics, Inc.

68 year

90 connections

Health Technology

Consumer Services

Finance

Profile

Charles Albright is currently the Chief Scientific Officer at Affinia Therapeutics, Inc. He previously worked as the VP-Genetically Defined Diseases & Genomics at Bristol Myers Squibb Co. from 2004 to 2016.
He also served as the Chief Scientific Officer & Executive VP at Editas Medicine, Inc. from 2016 to 2021.
Albright was an Assistant Professor at Vanderbilt University.
Albright received his undergraduate and doctorate degrees from Massachusetts Institute of Technology.

Charles Albright active positions

Companies	Position	Start
Affinia Therapeutics, Inc. Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies	Chief Tech/Sci/R&D Officer	2020-12-31

All active positions of Charles Albright

Former positions of Charles Albright

Companies	Position	End
EDITAS MEDICINE, INC.	Chief Tech/Sci/R&D Officer	2021-01-14
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	2016-07-31
Vanderbilt University Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

See the detail of Charles Albright's experience

Training of Charles Albright

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Charles Albright's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
Vanderbilt University Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
Editas Medicine, Inc. Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines	Health Technology
Affinia Therapeutics, Inc. Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies	Health Technology